Home › NCT05721859
M-Vizion™ Macroscopic Radiographic Study
RecruitingObservational study
Medacta M-Vizion™ Macroscopic Radiographic Study, Multi-center, Post-Market Outcomes Study
Who can join
Ages 21 to 80 · All sexes
Full eligibility criteria
Inclusion Criteria: * Must be able to read, understand, and provide written informed consent on the Institutional Review Board (IRB) approved Informed Consent Form (ICF). * Ability to understand and provide written authorization for use and disclosure of personal health information. * Subjects who are able and willing to comply with the study protocol and follow-up visits. * Patients requiring a revision total hip replacement. * Subjects undergoing revision THA who will receive an M-Vizion femoral component according to the indications for use. * Male and female patients ages 21 - 80 years of age at the time of surgery. Exclusion Criteria: * Patients with neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device. * Patients with a systemic or metabolic disorder leading to progressive bone deterioration. * Patients bone stock is compromised by disease or infection, which could possibly prevent adequate support and/or fixation to the prosthesis. * Patients with an active or suspected latent infection in or about the hip joint. * Patients that are incarcerated.
About the study
Study of the patient's subsidence after revision hip arthroplasty by assessing gross stem subsidence in the femoral canal.
What is being tested
- revision hip arthroplasty (device)
Sponsor: Medacta USA · Participants: 70 · Started: Oct 12, 2022
Contact the study team
- Emily Hord, CCRP · Phone: 331-208-4284
Official record on ClinicalTrials.gov — NCT05721859
Locations in the U.S.
| Illinois | Northwestern Medicine, Chicago |
| Massachusetts | Beth Israel Deaconess Medical Center, Boston New England Baptist Hospital, Boston |
| New Hampshire | Dartmouth Health, Lebanon |
| North Carolina | OrthoCarolina Research Institute, Inc., Charlotte |
| Pennsylvania | Geisinger Medical Center, Danville |
| Utah | University of Utah Department of Orthopaedics, Salt Lake City |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.